A 76-year-old man with a history of pulmonary tuberculosis was found to be sputum smear positive for acid-fast bacilli. The 16S rRNA sequence identified the culture isolate as Mycobacterium intermedium, the pathogenicity of which has not been confirmed. Chemotherapy with isoniazid, rifampin, and ethambutol resulted in clinical improvement.
CASE REPORTA 76-year-old man had a routine health checkup in 2002 when his chest radiograph showed thick fibrotic lesions in the apex of both lungs (Fig. 1, left panel). The smear of his sputum for acid-fast bacilli (AFB) was 2ϩ. He was referred to Sapporo Minami National Hospital for suspected pulmonary tuberculosis in October 2002. He denied any symptoms except occasional sputum production.He remembered being given a diagnosis of pulmonary tuberculosis at about 12 years of age without subsequent chemotherapy. Details of this episode had been lost, along with his Mycobacterium bovis BCG status. Medical history was otherwise unremarkable. No risk factors for AIDS were found.Physical findings were normal. Laboratory data were abnormal in showing an erythrocyte sedimentation rate (ESR) at 1 h of 72 mm and a C-reactive protein (CRP) level of 78.2 mg/liter. A tuberculin skin test resulted in 16 mm of induration. The computed tomography of the thorax showed a cavity with thick, irregular walls at the apex of the left lung abutting caudally the area of severe bronchiectasis. The lesions in the apex of the right lung were mostly thick fibrosis and pleural thickening.The sputum smear for AFB was repeated on three consecutive days, giving a 3ϩ result each time. An AMPLICOR nucleic acid amplification test (Roche Diagnostics, Tokyo, Japan) of one sample was all negative for Mycobacterium tuberculosis and Mycobacterium avium complex (3).Pending results of the cultures, we started isoniazid, rifampin, and ethambutol on a diagnosis of pulmonary mycobacteriosis possibly due to Mycobacterium kansasii, which is the second most prevalent nontuberculous mycobacterium after M. avium complex in Japan, considering the negative AMPLI-COR result. The clinical course was uneventful. After 2 months of therapy, both smear and culture of the sputum converted to negative, ESR and CRP level were normalized, and a chest radiograph showed clearing of the opacity inside the cavitary lesion of the left upper lobe (Fig. 1, right panel).The chemotherapy was continued until October 2003, for a total of 12 months. At a follow-up in March 2004, the sputum stayed negative for AFB, and there was no radiographic exacerbation.Cultures of the initial sputum specimens eventually yielded growth on both mycobacterial growth indicator tubes (BD Diagnostic Systems, Sparks, Md.) and egg-based solid medium (Ogawa medium; Nissui Pharmaceutical Co. Ltd., Tokyo, Japan). The isolated strain showed eugonic growth and photochromogenic character on solid medium. It was positive for urease but negative for nitrate reduction. We were unable to identify the isolate on solid medium by a DNA-DNA hybridization method with a DDH Mycobacteri...